Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

37.32
-0.0800-0.21%
Post-market: 37.320.00000.00%19:59 EDT
Volume:10.26M
Turnover:383.44M
Market Cap:166.63B
PE:9.32
High:37.65
Open:37.64
Low:37.17
Close:37.40
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.79
T/O Rate:0.32%
Dividend:1.79
Dividend Rate:4.78%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.12
PE(LYR):10.31

Loading ...

Novo Nordisk's Semaglutide Injection Gets Chinese Approval for MASH Treatment

MT Newswires Live
·
Sep 10

Novo Nordisk Advances Oral Semaglutide Trial in Obesity: What Investors Should Watch

TIPRANKS
·
Sep 10

Novo Nordisk A/S Series B Stock Falls Wednesday

Dow Jones
·
Sep 10

Novo Nordisk Advances DKK 15 Billion Share Buyback, Holding 1% of Capital in Treasury Stock

TIPRANKS
·
Sep 09

Novo Nordisk A/S Stock (NVO) Closed Down by 3.09% on Sep 8: Facts Behind the Movement

TradingKey
·
Sep 09

Movement Alert|Novo-Nordisk A/S Falls 3.08% in Regular Trading, Two Late-Stage Ziltivekimab Trials Halted as Pipeline Suffers Setback

Market Focus
·
Sep 09

GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could be Another Huge Market.

Dow Jones
·
Sep 09

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

MT Newswires Live
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live
·
Sep 08

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live
·
Sep 08

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement
·
Sep 08

Novo Nordisk (0QIU) Receives a Hold from Barclays

TIPRANKS
·
Sep 08

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

TIPRANKS
·
Sep 08

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg
·
Sep 08

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

TIPRANKS
·
Sep 08

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

TIPRANKS
·
Sep 08

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Dow Jones
·
Sep 08

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

TIPRANKS
·
Sep 07

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Reuters
·
Sep 07